Zhe‐Sheng Chen

Tongji University — China

Medicine · Health Sciences

99h-index41.2kcitations829works8.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(327), Cancer therapeutics and mechanisms(131), HIV/AIDS drug development and treatment(81), Pharmacological Effects and Toxicity Studies(53), Cancer Mechanisms and Therapy(43)

Publications829 total

Platelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma
Biology Direct·2025Open Access
Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy
Advanced Science·2025Open Access
HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment
Advanced Science·2025· 1 citedOpen Access
Fe-based multi-interfacial engineering composites for broadband electromagnetic wave absorption
Nano Research·2025Open Access
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: Olverembatinib
Experimental Cell Research·2025
Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147 <sup>+</sup> extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma
International Journal of Biological Sciences·2025Open Access
A Deep Learning-Generated Mixed Tumor–Stroma Ratio for Prognostic Stratification and Multi-omics Profiling in Bladder Cancer
Research·2025Open Access
[18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer
Clinical Nuclear Medicine·2025
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cells
Cancer Genetics·2025
Preface
Recent Patents on Anti-Cancer Drug Discovery·2025
PD‐L1 on Tumor‐Derived Extracellular Vesicles Induces CD8 <sup>+</sup> T Cell Terminal Exhaustion and Mediates Anti‐PD‐1 Resistance in Head and Neck Squamous Cell Carcinoma
Advanced Science·2025· 1 citedOpen Access
Exportin 1 inhibitor KPT‑330 reverses oxaliplatin resistance via p53 nuclear retention in colorectal cancer
International Journal of Molecular Medicine·2025Open Access
The Aging Gut–Brain Axis: Effects of Dietary Polyphenols and Metal Exposure
Chronic Diseases and Translational Medicine·2025Open Access
Gankyrin‐Protein Interactions in GI Cancers: A Novel Target of New Therapeutics
Chronic Diseases and Translational Medicine·2025Open Access
Dual‐Pedicle Tissue‐Engineered Trachea Promotes Biomimetic Cartilaginous Framework, Vascularization, and Epithelial Lining for Long‐Segment Tracheal Reconstruction
Advanced Science·2025Open Access
Tumor-Derived CTHRC1 Mediates ITGB3-Dependent Osteoclast Differentiation to Promote Prostate Cancer Bone Metastasis
2025Open Access
Bridging data and drug development: Machine learning approaches for next-generation ADMET prediction
Drug Discovery Today·2025· 2 cited
P3.12.07 Rezivertinib in EGFR-Mutated NSCLC Patients With Cns Metastases: Cns Efficacy From Phase 3 RAZOR Study
Journal of Thoracic Oncology·2025· 1 cited
P3.18.59 Resistance Mechanisms and Sequential Therapies Following 1St Line Lorlatinib in ALK+ NSCLC: A Real-World Study (LORES CTONG2501)
Journal of Thoracic Oncology·2025
Beyond the boundary: The emerging roles of ATP-binding cassette transporters in multidrug resistance (MDR) and therapeutic targeting in cancer
Drug Resistance Updates·2025· 3 cited
page 1 of 42Next →

Frequent Co-authors

Charles R. Ashby(11), Yehuda G. Assaraf(8), Gary D. Kruh(7), Amit K. Tiwari(7), Liuya Wei(5), Martin G. Belinsky(5), Jing‐Quan Wang(4), Leli Zeng(4), Hailin Tang(4), Liwu Fu(4), Pranav Gupta(3), Qingbin Cui(3), Kun Hee Lee(3), Robert W. Robey(3), Suresh V. Ambudkar(3), Hao Zeng(3), Irina Shchaveleva(3), Kamlesh Sodani(3), Qiu‐Xu Teng(3), Yanan Kong(3)